C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 209/08 (2006.01) A61K 31/404 (2006.01) A61K 31/416 (2006.01) A61K 31/4184 (2006.01) A61K 31/4192 (2006.01) C07D 209/12 (2006.01) C07D 209/30 (2006.01) C07D 231/56 (2006.01) C07D 235/06 (2006.01) C07D 249/18 (2006.01)
Patent
CA 2648729
The invention is directed to indole amide derivatives as EP4 receptor antagonists useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer. Pharmaceutical compositions and methods of use are also included.
L'invention concerne des dérivés d'indolamide comme antagonistes du récepteur EP4 qui sont utiles pour le traitement de maladies ou affections médiées par l'EP4, par exemple la douleur aiguë et chronique, l'ostéoarthrite, la polyarthrite rhumatoïde et le cancer. L'invention concerne également des compositions pharmaceutiques ainsi que des procédés d'utilisation.
Boyd Michael
Colucci John
Wang Zhaoyin
Merck Frosst Canada Ltd.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Indole amide derivatives as ep4 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole amide derivatives as ep4 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole amide derivatives as ep4 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1988918